For example, ANXA2 Y24, a SRC-regulated site [83], has recently been reported to correlate with invasiveness and metastatic events in pancreatic ductal adenocarcinoma [84], underlining the established role of MET in driving invasive growth during tumorigenesis [85]. Here, SRC is linked to pancreatic ductal adenocarcinoma.